Lupin
NSE: LUPIN
Healthcare
₹2183.007.500.34%(1D)
Performance Stats for Lupin
Day Range
Low: ₹2173.60
High: ₹2198.60
52 Week Range
Low: ₹1875.00
High: ₹2529.50
Open Price
2175.50Previous Close
2175.50Volume
381766.00Open Price
2175.50Previous Close
2175.50Volume
381766.00Fundamentals of Lupin
ROCE
27.47%
EPS
₹144.82
Dividend Yield
0.78%
P/E Ratio
16.61
P/B Ratio
3.51
Debt to Equity
0.03
Current Ratio
2.62
Sales Growth
14.30%
Profit Growth
33.41%
EBIT Growth
37.66%
Financials of Lupin
All values in Rs. Cr
All values in Rs. Cr
All values in Rs. Cr
Share Holding Pattern of Lupin
About Lupin
Lupin is an innovation led Transnational Pharmaceutical Company producing, developing and marketing a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally. The Company has signific...
Read more
Similar Sector Stocks
| Stocks | CMP |
| Aarey Drugs And Pharm | ₹80.75 4.99% |
| Aarti Drugs | ₹421.2 0.24% |
| Aarti Pharmalabs | ₹844.85 1.19% |
| Abbott India | ₹26550 0.51% |
Most Viewed Stocks
Open Interest (OI)
Lupin Options
| Price | OI | Volume |
Events Related to Lupin
Board Meeting
Aug 6, 2026
AGM
Aug 4, 2026
Dividend
Jul 17, 2026
Board Meeting
May 7, 2026
Board Meeting
Feb 12, 2026
News About Lupin
Lupin shares in focus after USFDA nod for drug to treat excessive daytime sleepiness
Aug 18, 2026
Lupin Q1 Review: Broad-Based Growth Impresses, But Systematix Sees US Competition Ahead — Check Target Price
Aug 10, 2026
Lupin Q1 PAT rises 16 pc at Rs 1,417 cr
Aug 7, 2026
Lupin Shares Rise After Q1 Profit, Revenue Beat Street Estimates
Aug 7, 2026
After Crushing Q1 Estimates, What"s Next For Lupin? Macquarie Makes Its Case
Aug 7, 2026
